What insurance policy changes affect CPT 33883?

There are 8 tracked policy changes affecting CPT 33883, including updates from Aetna, Independence Blue Cross. Each change may modify coverage criteria, reimbursement rates, or prior-authorization requirements.

Which payers have updated policy for CPT 33883?

Payers that have issued tracked updates for CPT 33883 include: Aetna, Independence Blue Cross.

How do I get notified when CPT 33883 policy changes?

Create a free account at PolicyChanges.app and save a search filtered to CPT 33883. You will receive a daily digest email whenever a new policy change references this code.

Why do payers change policies for CPT 33883?

Payers revise policies for individual billing codes to align with updated clinical guidelines, CMS rule changes, fraud and abuse prevention measures, or network cost-management goals. Changes can affect medical necessity criteria, place-of-service restrictions, bundling rules, or whether a code requires prior authorization.

33883 — Inserting a heart device extension that was implanted later than the initial valve procedure.: Insurance Policy Changes

33883 Insurance Policy Changes

CPT 33883, in plain terms, covers Inserting a heart device extension that was implanted later than the initial valve procedure. CPT 33883 is referenced in 8 tracked payer policy changes from Aetna and Independence Blue Cross. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for CPT 33883 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

High impact

Endovascular Repair of Aortic Diseases (CPB 0651, reviewed 2026-04-24)

Aetna·Effective Apr 24, 2026

Aetna has updated its Clinical Policy Bulletin 0651 (effective 2026-04-24) clarifying coverage for endovascular repair of aortic diseases, including specific FDA-approved procedures for infrarenal abdominal aortic aneurysms, descending thoracic aortic aneurysms, aortic coarctation, and pulmonary artery stenosis/hypoplasia. The policy also designates certain procedures as experimental/investigational (e.g., Nellix device, GORE EXCLUDER thoraco-abdominal branch endoprosthesis, total endovascular aortic arch repair), which will not be covered. Billing teams must verify procedure eligibility and device FDA approval status before claim submission.

33883 Insurance Policy Changes

Endovascular Repair of Aortic Diseases (CPB 0651, reviewed 2026-04-24)

MA00.019k, Radiologic Guidance and/or Supervision and Interpretation of a Procedure

MA11.062d, Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions

MA11.062d, Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions

11.02.17j, Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions

11.02.17j, Endovascular Stent Graft Repair of Thoracic Aortic Aneurysms and Nonaneurysmal Lesions

Endovascular Repair of Aortic Diseases (CPB 0651, reviewed 2026-09-25)

00.10.36v, Radiologic Guidance and/or Supervision and Interpretation of a Procedure